Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral: Vanier Canada Graduate Scholarships

Université Laval

$150,000.00

New insights into the diagnosis and treatment of low flow aortic stenosis

EF 2008-09

Résumé
Although patients with severe aortic stenosis (AS) and severely depressed ventricular function represent approximately 5-10 % of AS patients, they also represent the most controversial and challenging subset. In the setting of a low cardiac output, it is difficult to separate patients with true severe AS (TS AS) from those with pseudosevere AS (PS AS). The distinction between these 2 groups is essential because the patients with TSAS will generally benefit of aortic valve replacement (AVR), whereas the patients with PS AS will not. Beyond the distinction between TS AS and PS AS, it is also important to assess the extent of impairment of the cardiac muscular function because patients with more severe impairment of muscular function undergoing AVR have a very high risk of mortality regardless of the degree of AS. Unfortunately, the echocardiographic indices currently used to assess the severity of valvular obstruction and the cardiac function in patients with low flow AS are far from being optimal, and as a consequence, several patients are misdiagnosed and thus do not receive the appropriate therapies. The first objective of this prospective multicenter study is to develop and validate new indices and criteria based on dobutamine stress echocardiography (DSE), computed tomography (CT) imaging, and cardiac hormones (BNP) that will contribute: (1) to better separate TS AS from PS AS, (2) to accurately assess the extent of cardiac function impairment, and (3) to better predict the hemodynamic, functional, and clinical outcomes in the patients with low flow AS. We believe that a strategy based on DSE, CT, and BNP will contribute to improve the risk stratification and the clinical decision making in these patients. The second objective is to compare the results of different types of treatment including medical treatment, AVR and transcatheter valve implantation. The latter is a new emerging technology that provides a less invasive alternative to AVR in high risk patients.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
184563
Name
Clavel Marie-Annick
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Doctoral Research Awards - A
Projecttitle
New insights into the diagnosis and treatment of low flow aortic stenosis
Programtype2
Studentship Programs
Orgnameinp2
Université Laval
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Aortic Stenosis; Aortic Valve Surgery; Biomarkers; Doppler-Echocardiography; Heart Failure; Heart Valve Prosthesis; Hemodynamics
Abstract
Although patients with severe aortic stenosis (AS) and severely depressed ventricular function represent approximately 5-10 % of AS patients, they also represent the most controversial and challenging subset. In the setting of a low cardiac output, it is difficult to separate patients with true severe AS (TS AS) from those with pseudosevere AS (PS AS). The distinction between these 2 groups is essential because the patients with TSAS will generally benefit of aortic valve replacement (AVR), whereas the patients with PS AS will not. Beyond the distinction between TS AS and PS AS, it is also important to assess the extent of impairment of the cardiac muscular function because patients with more severe impairment of muscular function undergoing AVR have a very high risk of mortality regardless of the degree of AS. Unfortunately, the echocardiographic indices currently used to assess the severity of valvular obstruction and the cardiac function in patients with low flow AS are far from being optimal, and as a consequence, several patients are misdiagnosed and thus do not receive the appropriate therapies. The first objective of this prospective multicenter study is to develop and validate new indices and criteria based on dobutamine stress echocardiography (DSE), computed tomography (CT) imaging, and cardiac hormones (BNP) that will contribute: (1) to better separate TS AS from PS AS, (2) to accurately assess the extent of cardiac function impairment, and (3) to better predict the hemodynamic, functional, and clinical outcomes in the patients with low flow AS. We believe that a strategy based on DSE, CT, and BNP will contribute to improve the risk stratification and the clinical decision making in these patients. The second objective is to compare the results of different types of treatment including medical treatment, AVR and transcatheter valve implantation. The latter is a new emerging technology that provides a less invasive alternative to AVR in high risk patients.
Competitiondate
200811
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Clavel, Marie-Annick
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~